City of Hope Cancer Symposium for Clinicians Will Teach Best Practices
October 5, 2015

Four-Day Multidisciplinary Symposium Will Unite Leading Experts on Most Up-to-Date Treatments

Contact
Tami Dennis
800-888-5323
[email protected]

DUARTE, Calif. — Treating cancer has become increasingly complex. Even as treatment options have increased, so too has knowledge of the biological underpinnings and genetic diversity of the disease, which is of course not one illness but a multitude of illnesses.  To help clinicians stay abreast of current best practices in the treatment of cancer, City of Hope is offering an intensive educational program for internists, family practitioners, gynecologists, surgeons, medical and surgical oncologists, urologists, dermatologists and other health care professionals interested in the treatment of people with cancer.

The Multidisciplinary Approaches to Cancer Symposium will offer lectures, case discussions and interactive question-and-answer sessions featuring City of Hope’s internationally renowned cancer specialists. In these sessions, these experts will profile and discuss clinical and technical advances, promising clinical trials data, national guidelines, and key controversies in the management of breast cancer, lung cancer, CNS tumors, gastrointestinal malignancies, melanoma, genitourinary malignancies, head and neck cancer, gynecologic cancer, and hematologic malignancies.

Over the course of the four-day Continuing Medical Education program, to be held Nov. 5-8 at Wynn Encore in Las Vegas, participants will gain an enhanced ability to interpret and apply best treatment practices for their own patients.   

“City of Hope’s unique translational research model means that we unite the best oncologists in the field with the best researchers. Together, they are experts not just in today’s most effective treatments, but in tomorrow’s as well,” said Steven T. Rosen, provost and chief scientific officer at City of Hope, an independent biomedical research institution and cancer treatment center near Los Angeles.  “As faculty of such a preeminent cancer center, they understand they have an obligation to share their knowledge with the rest of the world, in order to improve care for everyone.”

Among the dozens of sessions will be: “New Targeted Agents in Breast Cancer,” “Advances in Evaluation and Management of Early Stage Lung Cancer,” “Novel Concepts In the Treatment of Metastatic Castrate Resistant Prostate Cancer,” “What Oncologists Can Learn From Their Genetics Colleagues: Genomics and Cancer Risk Assessment,” “What Solid Tumor Oncologists Can Learn From Hematology Colleagues: Promise of New Agents,” “Role of Liver Resection in Non-Gastrointestinal Primary Cancers,” and many more.

Each year, an estimated 1,658,370 people in the U.S. are diagnosed with cancer, and an estimated 589,430 people die of the disease. At the Multidisciplinary Approaches to Cancer Symposium, clinicians can learn how remain current in their field, ultimately changing those numbers.

City of Hope is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  City of Hope designates this live activity for a maximum of 20 AMA Category 1 Credit(s).
 

***


About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, California, just northeast of Los Angeles, with community clinics in southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on  Facebook, Twitter, YouTube or Flickr.